Lozano R - Search Results

1

Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome.

Kaufmann WE, Raspa M, Bann CM, Gable JM, Harris HK, Budimirovic DB, Lozano R; FORWARD Consortium. Kaufmann WE, et al. Among authors: lozano r. J Autism Dev Disord. 2024 Feb;54(2):725-737. doi: 10.1007/s10803-022-05821-7. Epub 2022 Nov 28. J Autism Dev Disord. 2024. PMID: 36441429

2

Genomic studies in fragile X premutation carriers.

Lozano R, Hagerman RJ, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. Lozano R, et al. J Neurodev Disord. 2014;6(1):27. doi: 10.1186/1866-1955-6-27. Epub 2014 Jul 30. J Neurodev Disord. 2014. PMID: 25170347 Free PMC article.

3

Modulation of the GABAergic pathway for the treatment of fragile X syndrome.

Lozano R, Hare EB, Hagerman RJ. Lozano R, et al. Neuropsychiatr Dis Treat. 2014 Sep 16;10:1769-79. doi: 10.2147/NDT.S42919. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25258535 Free PMC article. Review.

4

Translational research guided by animal studies in Fragile X Disorders.

Hagerman R, Lozano R, Schneider A. Hagerman R, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):100. doi: 10.5582/irdr.2014.01033. Intractable Rare Dis Res. 2014. PMID: 25606359 Free PMC article. No abstract available.

5

Fragile X spectrum disorders.

Lozano R, Rosero CA, Hagerman RJ. Lozano R, et al. Intractable Rare Dis Res. 2014 Nov;3(4):134-46. doi: 10.5582/irdr.2014.01022. Intractable Rare Dis Res. 2014. PMID: 25606363 Free PMC article. Review.

6

Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders.

Chechi T, Siyahian S, Thairu L, Hagerman R, Lozano R. Chechi T, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):147-52. doi: 10.5582/irdr.2014.01025. Intractable Rare Dis Res. 2014. PMID: 25606364 Free PMC article.

7

Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases.

Muzar Z, Adams PE, Schneider A, Hagerman RJ, Lozano R. Muzar Z, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):162-5. doi: 10.5582/irdr.2014.01023. Intractable Rare Dis Res. 2014. PMID: 25606366 Free PMC article.

8

Parent-delivered touchscreen intervention for children with fragile X syndrome.

Díez-Juan M, Schneider A, Phillips T, Lozano R, Tassone F, Solomon M, Hagerman RJ. Díez-Juan M, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):166-77. doi: 10.5582/irdr.2014.01026. Intractable Rare Dis Res. 2014. PMID: 25606367 Free PMC article.

9

Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Lozano R, Martinez-Cerdeno V, Hagerman RJ. Lozano R, et al. Curr Pharm Des. 2015;21(34):4972-4979. doi: 10.2174/1381612821666150914121038. Curr Pharm Des. 2015. PMID: 26365141 Free PMC article. Review.

10

Aging in Fragile X Premutation Carriers.

Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. Lozano R, et al. Cerebellum. 2016 Oct;15(5):587-94. doi: 10.1007/s12311-016-0805-x. Cerebellum. 2016. PMID: 27334385 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

758 results

Search Page